Brazil to contribute to research into new drug against COVID-19

BRASILIA. KAZINFORM The Oswaldo Cruz Foundation (Fiocruz) will be part of an international phase-three study into drug Molnupiravir, manufactured by pharmaceutical company MSD.

Related Keywords

Brasilia ,Distrito Federal ,Brazil ,Rio De Janeiro ,Estado Do Rio ,Fiocruz ,Julio Croda ,Margareth Dalcolmo ,Oswaldo Cruz Foundation Fiocruz ,Oswaldo Cruz Foundation ,Mato Grosso ,Researchers Julio Croda ,World News ,Coronavirus Pandemic ,Contribute ,Research ,Against ,Covid 19 ,